Kalos Management, Inc. Takeda Pharmaceutical CO LTD Transaction History

Kalos Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$16.3 - $17.26 $2.08 Million - $2.2 Million	-127,540 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$16.55 - $18.64 $93,474 - $105,278	-5,648 Reduced 4.24%	127,540 $2.09 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $753,186 - $896,972	45,074 Added 51.15%	133,188 $2.23 Million
Q4 2020 Feb 11, 2021	SELL	$15.39 - $18.97 $73,795 - $90,961	-4,795 Reduced 5.16%	88,114 $1.56 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $205,388 - $230,491	-12,011 Reduced 11.45%	92,909 $1.59 Million

Q2 2020 Aug 13, 2020	SELL	$14.59 - $19.5 $179,179 - $239,479	-12,281 Reduced 10.48%	104,920 $1.94 Million
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $155,719 - $242,907	-11,960 Reduced 9.26%	117,201 $2.06 Million
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $2.18 Million - $2.69 Million	129,161 New	129,161 $2.55 Million

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.